The store will not work correctly when cookies are disabled.
5-Fluoromethyl-1-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidine-2,4-dione
ID: ALA2368785
Cas Number: 101527-45-1
PubChem CID: 127931
Max Phase: Preclinical
Molecular Formula: C10H13FN2O5
Molecular Weight: 260.22
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1CF
Standard InChI: InChI=1S/C10H13FN2O5/c11-2-5-3-13(10(17)12-9(5)16)8-1-6(15)7(4-14)18-8/h3,6-8,14-15H,1-2,4H2,(H,12,16,17)/t6-,7+,8+/m0/s1
Standard InChI Key: BQLWSXSBUAEINE-XLPZGREQSA-N
Molfile:
RDKit 2D
18 19 0 0 1 0 0 0 0 0999 V2000
2.1081 -1.7445 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7726 -2.4981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2575 -3.1656 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.6232 -1.0770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9286 -1.6582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4135 -2.3257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0780 -3.0793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8782 -0.2924 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7982 -1.0770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2107 0.1925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5433 -0.2924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9521 -2.5844 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5629 -3.7468 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2340 -2.2394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2413 -0.0375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7190 -2.9069 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.2107 1.0175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4963 1.4300 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 1 1 1
5 1 1 0
6 5 2 0
7 6 1 0
8 4 1 0
4 9 1 0
10 8 1 0
11 9 1 0
12 2 2 0
13 7 2 0
14 6 1 0
11 15 1 6
16 14 1 0
10 17 1 1
18 17 1 0
3 7 1 0
10 11 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 260.22 | Molecular Weight (Monoisotopic): 260.0808 | AlogP: -1.35 | #Rotatable Bonds: 3 |
Polar Surface Area: 104.55 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.38 | CX Basic pKa: ┄ | CX LogP: -1.51 | CX LogD: -1.51 |
Aromatic Rings: 1 | Heavy Atoms: 18 | QED Weighted: 0.62 | Np Likeness Score: 0.75 |
References
1. Matulic-Adamic J, Takahashi K, Chou TC, Gadler H, Price RW, Reddy AR, Kalman TI, Watanabe KA.. (1988) Nucleosides. 150. Synthesis and some biological properties of 5-monofluoromethyl, 5-difluoromethyl, and 5-trifluoromethyl derivatives of 2'-deoxyuridine and 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyluracil., 31 (8): [PMID:2840503] [10.1021/jm00403a026] |